[1,2,4]Triazolo[1,5-a]pyrimidin-7(1H)-one, 2-(4-methylphenyl)-5-(phenylmethyl)- manufacturers
|
| | [1,2,4]Triazolo[1,5-a]pyrimidin-7(1H)-one, 2-(4-methylphenyl)-5-(phenylmethyl)- Basic information |
| | [1,2,4]Triazolo[1,5-a]pyrimidin-7(1H)-one, 2-(4-methylphenyl)-5-(phenylmethyl)- Chemical Properties |
| Boiling point | 470.5±48.0 °C(Predicted) | | density | 1.28±0.1 g/cm3(Predicted) | | pka | -1.94±0.40(Predicted) |
| | [1,2,4]Triazolo[1,5-a]pyrimidin-7(1H)-one, 2-(4-methylphenyl)-5-(phenylmethyl)- Usage And Synthesis |
| Uses | GABAA receptor agent 8 (compoud 5e) is a potent GABAA receptor positive modulator. GABAA receptor agent 8 shows anticonvulsant activity in vitro and in vivo with low neurotoxicity. GABAA receptor agent 8 has the potential for the research of epilepsy[1]. | | in vivo | GABAA receptor agent 8 (compoud 5e) shows anticonvulsant activity in mice with an ED50 of 40.95 mg/kg and an TD50 of 372.39 mg/kg[1].
GABAA receptor agent 8 specifically attenuates PTZ-induced seizures but not MES-induced seizures in mice[1]. | | References | [1] Huang L, et al. Discovery of [1,2,4]-triazolo [1,5-a]pyrimidine-7(4H)-one derivatives as positive modulators of GABAA1 receptor with potent anticonvulsant activity and low toxicity. Eur J Med Chem. 2020 Jan 1;185:111824. DOI:10.1016/j.ejmech.2019.111824 |
| | [1,2,4]Triazolo[1,5-a]pyrimidin-7(1H)-one, 2-(4-methylphenyl)-5-(phenylmethyl)- Preparation Products And Raw materials |
|